Congrats to DNDN longs. One question that I wanted to ask--> What are the most credible MAB therapies being developed for prostate cancer? Several companies have had anti-PSMA ABs in development (MLNM MEDX). If I were DNDN, I would see an anti-prostate cancer MAB as a competitive threat.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.